Assessing the Long-Term Health Effects of Antimalarial Use – New Report Feb. 25

A new report from the National Academies of Sciences, Engineering, and Medicine assesses whether there is an association between antimalarial drug use and long-term neurologic, psychiatric, and other health effects -- including anxiety, depression, and the development of symptoms that mirror posttraumatic stress disorder (PTSD).

In addition to U.S. service members and veterans, the report also considered other populations that use antimalarial drugs, including Peace Corps volunteers, travelers, people living in malaria-endemic areas, and research volunteers.

Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis also identifies research priorities to address gaps in knowledge about the safety of antimalarials.

Members of the committee that authored the report will present their findings and answer questions during a public release event starting at 10 a.m. EST on Tuesday, Feb. 25.

Details:
Tuesday, Feb. 25, 10 a.m. – 11 a.m.
National Academies’ Keck Center
Room K208
500 5th St. NW
Washington, DC 20001

Participants:


Register for the in-person event or webcast here.

Advance copies of the report will be available to reporters only beginning at noon EST Monday, Feb. 24.

The report is embargoed and not for public release before 10 a.m. EST Tuesday, Feb. 25.

Reporters who wish to obtain copies should contact the Office of News and Public Information at tel. 202-334-2138 or e-mail news@nas.edu.

Follow us:
Twitter @theNASEM
Instagram @thenasem
Facebook @NationalAcademies
Office of News and Public Information